{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62175-458",
      "generic_name": "Buprenorphine and Naloxone",
      "labeler_name": "Lannett Company, Inc.",
      "dea_schedule": "CIII",
      "brand_name": "Buprenorphine and Naloxone",
      "active_ingredients": [
        {
          "name": "BUPRENORPHINE",
          "strength": "8 mg/1"
        },
        {
          "name": "NALOXONE",
          "strength": "2 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "62175-458-32",
          "description": "30 TABLET in 1 BOTTLE (62175-458-32)",
          "marketing_start_date": "20160919",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Lannett Company, Inc."
        ],
        "rxcui": [
          "351266",
          "351267"
        ],
        "spl_set_id": [
          "14eaa94a-cc8a-4e1e-8cfb-5c976c96c606"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175691",
          "N0000000154",
          "N0000175689",
          "N0000175685"
        ],
        "pharm_class_epc": [
          "Opioid Antagonist [EPC]",
          "Partial Opioid Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Opioid Antagonists [MoA]",
          "Partial Opioid Agonists [MoA]"
        ],
        "unii": [
          "36B82AMQ7N",
          "40D3SCR4GZ"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "2f25fc02-629e-4539-82b9-f22f6937d72e",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBLINGUAL"
      ],
      "marketing_start_date": "20160919",
      "product_id": "62175-458_2f25fc02-629e-4539-82b9-f22f6937d72e",
      "application_number": "ANDA205022",
      "brand_name_base": "Buprenorphine and Naloxone",
      "pharm_class": [
        "Opioid Antagonist [EPC]",
        "Opioid Antagonists [MoA]",
        "Partial Opioid Agonist [EPC]",
        "Partial Opioid Agonists [MoA]"
      ]
    }
  ]
}